Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation
Visa to Move European Headquarters to London’s Canary Wharf
Magnum Audit Flags Governance Issues at Ben & Jerry’s Foundation Ahead of Spin-Off
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals
Tesla Faces 19% Drop in UK Registrations as Competition Intensifies
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 



